Martel
BenoƮt Martel, Gilly Sur Isere FR
Patent application number | Description | Published |
---|---|---|
20140343870 | DETERMINATION OF ACCEPTOR AND DONOR DOPANT CONCENTRATIONS - The concentrations of three acceptor and donor dopants of a semiconductor sample are determined by solving a system of three equations. A first equation is obtained by measuring the free charge carrier concentration of the sample at low temperature, and in then confronting these measurements with a mathematical model suitable for these temperatures. A second equation is obtained by measuring a mobility of the majority charge carriers and comparing it with its mathematical expression. A third equation between the dopant concentrations is established knowing the activation energy of the shallower majority dopant in the bandgap of the semiconductor material. When the activation energy of this majority dopant is equal to its maximum value, this third equation is derived from the electro-neutrality of the silicon at ambient temperature. When, the activation energy differs from its maximum value, the concentration of this majority dopant can be deduced directly from its activation energy. | 11-20-2014 |
Bernard Martel, Nieppe FR
Patent application number | Description | Published |
---|---|---|
20080254094 | Biomaterials Carrying Cyclodextrines Having Improved Absorption Properties and Used for the Progressive and Delayed Release of Therapeutic Molecules - The present invention relates to a method of preparation of a biomaterial containing at least one bioactive molecule from a base biomaterial, characterized by the following successive operations carried out on the aforesaid base biomaterial: | 10-16-2008 |
Michel Martel, Le Chesnay FR
Patent application number | Description | Published |
---|---|---|
20090218468 | MECHANISM FOR LOCKING THE RAILS OF A MOTOR VEHICLE SEAT - A mechanism for locking rails of a motor vehicle seat including a first rail joined to a structure element along a longitudinal axis of the vehicle, a second rail sliding in the first rail and supporting the seat frame of the seat, a first cross-bar pivoting in the second rail along an axis essentially perpendicular to the two rails coaxially held in a desired position relative to one another via a return mechanism of the first cross-bar, and a second cross-bar, which includes a first protuberance oriented toward the front of the seat and a second protuberance oriented toward the rear of the seat, connected to the first cross-bar so that the longitudinal displacement of the seat is controlled by the two protuberances. | 09-03-2009 |
Olivier Martel, Bains Sur Oust FR
Patent application number | Description | Published |
---|---|---|
20100302436 | WEBCAM-TYPE CAMERA DESIGNED FOR MOUNTING ON A SCREEN - The invention relates to a camera designed to be mounted on a screen, including an attachment segment ( | 12-02-2010 |
Paul Martel, St. Raphael FR
Patent application number | Description | Published |
---|---|---|
20110243181 | Test device for checking a pre-vacuum steam sterilization apparatus - Test device capable of checking the quality of the sterilizing steam in a pre-vacuum apparatus intended for sterilization, including a receptacle ( | 10-06-2011 |
Paul Martel, Vallauris FR
Patent application number | Description | Published |
---|---|---|
20110250104 | Sterilization Box Seal Device - A sterilization box seal device comprising a shaft ( | 10-13-2011 |
Philippe Martel, Biot FR
Patent application number | Description | Published |
---|---|---|
20140371147 | COMBINATION OF A PROSTAGLANDIN RECEPTOR AGONIST AND AN MC1R RECEPTOR AGONIST FOR THE TREATMENT AND/OR PREVENTION OF PIGMENTATION DISORDERS - A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo. | 12-18-2014 |
20150045719 | COMBINATION OF A MC1R RECEPTOR AGONIST AND UVB FOR THE TREATMENT AND/OR PREVENTION OF PIGMENTATION DISORDERS - A system comprising a combination of at least one MC1R receptor agonist and a source of NB-UVB, wherein said system is adapted for simultaneous or sequential use of said MC1R receptor agonist and said NB-UVB in amounts effective for the treatment and/or prevention of dermatological conditions linked to a hypopigmentation. | 02-12-2015 |